{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"GeneDx Holdings Corp."},"Symbol":{"label":"Symbol","value":"WGS"},"Address":{"label":"Address","value":"United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Retail: Computer Software & Peripheral Equipment"},"Sector":{"label":"Sector","value":"Technology"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut."},"CompanyUrl":{"label":"Company Url","value":"https://www.genedx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Karen Ponchner","title":"Head-Operations"},{"name":"Katherine A. Stueland","title":"President, Chief Executive Officer & Director"},{"name":"Paul Kruszka","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}